deltatrials
Completed PHASE2 NCT00003050

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Weekly Paclitaxel During Radiation Therapy for Locally Advanced Breat Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Breast Cancer
Interventions cyclophosphamide doxorubicin hydrochloride paclitaxel radiation therapy surgical procedure tamoxifen citrate
Updated 6 times since 2017 Last updated: May 20, 2014 Started: Apr 30, 1997 Primary completion: Mar 31, 2000 Completion: Mar 31, 2000

Listed as NCT00003050, this PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 6 times since 1997, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Apr 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • University of Southern California
Data source: University of Southern California

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Jacksonville, United States
  • • Los Angeles, United States